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Abstract
While it is known that matrixmetalloproteinase-2 (MMP-2) is present in dentin, its distribution and
role in human dentin formation and pathology are not well understood.
OBJECTIVE—To characterize the distribution of MMP-2 in human coronal dentin.
METHODS—Immunohistochemistry was used to investigate the distribution of MMP-2 in coronal
dentin. Freshly extracted human premolars and 3rd molars (age range 12–30) were fixed with
formaldehyde, demineralized with 10% EDTA (pH=7.4) and embedded in paraffin. Five µm serial
sections were made and subjected to immunohistochemical analysis using a specific monoclonal
anti-MMP-2 antibody. Immunoreactivity was visualized with 3,3’-diaminobenzidine substrate and
observed under light microscopy. ImageJ software was used to calculate the relative amount/
distribution of MMP-2.
RESULTS—The analysis revealed immunoreactivity for MMP-2 throughout human coronal dentin.
However, intense immunoreactivities were identified in a 90–200 µm zone adjacent to the pre-dentin
as well as a 9–10 µm wide zone adjacent to the dentinoenamel junction (DEJ).
CONCLUSION—MMP-2 has a specific distribution in human coronal dentin indicating it’s
involvement in extracellular matrix organization in predentin and the establishment of the DEJ.
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INTRODUCTION
Dentin is essentially composed of two phases, mineral and fibrillar collagen/noncollagenous
matrix. Early research of dentinogenesis proposed that odontoblasts synthesize a type of
collagenase and an inhibitor which bind to the collagen fibrils of the matrix, forming a collagen/
collagenase/inhibitor complex.1 The collagenase was then identified in human mineralized
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dentin matrix, as a~68 kDa protein, functioned at neutral pH and was characterized as a matrix
metalloproteinase(MMP).1,2
MMPs 2, 3, 9 & 20 have since been identified in embryonic mouse tooth germ dentin and piglet
tooth germ odontoblasts suggesting that these proteases may be involved in dentin matrix
formation.3,4 MMP-2 in forming rat incisors may be concentrated in an area adjacent to the
dentinoenamel junction (DEJ), in association with odontoblastic processes and odontoblast
cell bodies.5 In contrast to MMP-2, a tissue inhibitor of MMPs (TIMP-1) may be in low
concentration adjacent to the DEJ and may be increased in concentration in the predentin in
forming rat incisors.5 TIMP-1 has been identified in human root dentin and its concentration
increases from the external dentin towards the predentin area (towards the pulp).6
MMP-2 (Gelatinase A) in both pro(~72kDa) and active(~68kDa) forms has been identified in
human dentin.7,8 Recently MMP-8 (Collagenase-2) and MMP-9 (Gelatinase B) have been
suggested to be present in human dentin.8,9 MMP-2 is the predominant MMP in mineralized
dentin and may be associated with the collagen matrix but not the hydroxyapatite.7
The evidence in support of the theory that host derived proteinases, in the form of various types
of MMPs, are involved in dentin caries pathogenesis is increasing.10,11 MMP-2, an enzyme
capable of digesting gelatin/collagen, has been suggested to be involved in dentin caries.7,8
However, due mainly to the variation of origin and preparation of dentin among studies, the
distribution, activity and biological function of MMP-2 in this tissue are still not well
understood. Despite the significant advancement made with regard to the potential relationship
between host-derived MMPs and caries progression, some of the fundamental issues such as
the location of MMPs, their association with collagen matrix, mechanisms of MMP activation,
etc. still remain unclear.
In this study, as a first step toward understanding the role of MMP-2 in human dentin biology
and pathology, we investigated the relative distribution of MMP-2 in human coronal dentin
using immunohistochemical (IHC) methodologies. The purpose of this study was to test the
null hypothesis that there is no difference in the mean level of maximum MMP-2
immunoreactivity of inner, middle and outer regions of coronal dentin isolated from extracted
human premolars and 3rd molars.
MATERIALS AND METHODS
This research was approved by the UNC Biomedical Institutional Review Board.
Sample preparation
Fifteen non-carious human 3rd molars and premolars with closed apices were placed in 10%
formaldehyde immediately after extraction and fixed for 72 hours at 4°C. (Table 1) The teeth
were sectioned using a Bueler Isomet (Bueler. Corp., Lake Bluff, IL) diamond impregnated
slow speed saw (Isomet) @ 100rpm with ~2° water cooling.(Figure 1) The 1.5 mm mesio-
distal (M-D) or bucco-lingual (B-L) sections were demineralized with 10% EDTA for 5 weeks
and placed in phosphate buffered saline, pH 7.4, (PBS). All demineralized specimens were
then parafinized and sectioned.
A microtome (Leica Jung RN 2045) was used to obtain 5µm sections from each specimen.
Immunohistochemical Analysis
Five slides of each subject (10 sections) were deparafinized with xylene, treated with 100%
ethanol (EtOH) for 2 minutes, 50%EtOH for 2 minutes and deionized water (dH2O) for 2
minutes.
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To better expose the epitopes the sections were then treated with 60 µl of Proteinase K (20
micrograms (µg)/mlPBS)(Proteinase K, recombinant, PCR Grade, Roche Applied Science) for
20 minutes, and then washed with dH2O for 1 minute. The sections were placed in a 0.3%
H2O2/EtOH solution for 30 minutes and washed in dH2O.
One section on each slide was then reacted with 30µl of a 100 µg stock solution anti-MMP-2
(α-MMP-2) (Calbiochem:IM33L:Anti-MMP-2 (Ab-3) Mouse mAb (42-5D11), EMD
Biosciences, Inc, La Jolla, CA) diluted (1:25) in PBS, blocked with normal horse serum (1:66)
for overnight at 4°C in a humidor. As a negative control, some sections were not reacted with
the primary antibody but were incubated with PBS with normal horse serum (1:66). After
incubation, sections were washed 3 times for 5 minutes each with PBS. A 30 µl volume
biotinylated horse anti-mouse IgG immunoglobulins (α-mouseIgG)/PBS solution (1:200)
blocked with normal horse serum (1:66) was prepared and incubated with the sections for 30
minutes.
After incubation with the biotinylated secondary antibody, the sections were washed with PBS,
treated with 30µl of an avidin DH (1:100) and biotinylated horseradish peroxidase H (1:100)
complex was placed over the sections and incubated for 30 minutes. The reagents used were
part of the Vectastain® ABC Kit (Vector Laboratories, Inc. Burlingame, CA).
The sections were then washed with PBS, each section was reacted with 30 µl of a 3,3’-
diaminobenzidine (DAB) solution, (DAB Substrate Kit®, Vector Laboratories, Inc.
Burlingame, CA) for 12 minutes and the reaction was stopped by immersion in dH2O. Initial
IHC studies were counterstained with hematoxylin for 5 seconds before fixation. These
sections were then dehydrated via 50% EtOH, 100% EtOH, Xylene washes, 5 minutes each,
and then enclosed under a slide cover with DPX and dried.
Specificity of the Antibody
The monoclonal antibody used for these studies was commercially obtained from
Calbiochem® (see above). The antibody was generated in mouse against the sequence located
in the hinge region of human MMP-2 (amino acids 468-483). The antibody recognizes MMP-2
in both its ~72kDa latent and ~66 kDa active forms. Recombinant human MMP-2 (rhMMP-2)
(MMP-2, Active, Human, Recombinant, Calbiochem®, EMD Biosciences, Inc., La Jolla, CA,
USA) generated from Chinese hamster ovary cells (~70.2 kDa proMMP-2 and ~60.9 kDa
MMP-2) was used as a positive control.
To establish antibody specificity for MMP-2 as well as MMP-2 gelatinolytic activity, human
third molars, obtained from the same subjects whose teeth were used for
immunohistochemistry, were obtained immediately after extraction and placed on dry ice until
disinfection. The teeth were disinfected in a 1% Thymol solution for 5 days @ 4°C. All
specimens were sectioned with the Isomet @ 100rpm with water/ice cooling in the following
sequence: 1) The roots were removed and the crowns were divided to expose the pulp chambers
2) Pulp tissue and predentin was removed from each section using a #12 scalpel blade and
dental scaling instruments. Enamel was removed with the Isomet slow speed saw.
Coronal dentin from multiple teeth was pulverized for 5 minutes in liquid N2 by a freezer mill
(SPEX CertiPrep® 6759 Freezer/Mill, Metuchen, NJ, USA), washed with cold dH2O and
lyophilized. The lyophilized samples were then extracted with 0.33 M EDTA/ 2M Guanidine-
HCl (pH 7.4) at 4°C. After 48 hours extraction the samples were centrifuged at 4500 rpm for
10 minutes and the pellet was extracted for another 48 hrs. Upon completion of the second
extraction the supernatents were combined and dialyzed against cold dH2O and lyophilized.
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A 1 or 2 mg of each extract was dissolved in tris-glycine SDS sample buffer for analysis using
Western blotting and gelatin zymography.
Quantitative evaluation
Images of the MMP-2 immunoreacted and control sections were obtained with a Nikon
Microphot FXA® microscope coupled with a QImaging® MP-3 digital camera and
QCapture® Image Software. Images were processed and analyzed with ImageJ 1.36b software.
(Wayne Rashband, National Institutes of Health, USA)
RGB (24 bit) color (Red(8 bit), Green(8 bit), Blue(8 bit)) images were then converted to gray
scale (8 bit) images (0–255, where 0 is black, 255 is white, and every point in between is a
shade of gray). The gray scale has 256 interger levels of gray. Background gray levels were
subtracted in order to correctly measure the gray scale level at each pixel across the image.
The formula used to obtain a plot of values in the grayscale range of 0–255 was as follows:
(Image 1 − Image 2)K1 + K2 = Image 2*
Image 1 = image of section with or without α-MMP-2
Image 2 = background (image contributions from the light source, lens and camera)
K1 = 1
K2 = 128
Image 2* = corrected resulting image displayed on the grayscale between 0 and 255.
The formula made the assumption that any RGB value above 255 would be displayed as 255
and any RGB below 0 would be displayed as 0. The grayscale level at each pixel along a 1-
pixel wide region spanning the pulp, predentin, dentin and DEJ was measured.(Figure 2) These
gray scale values were used as a measure of the level of MMP-2 immunoreactivity.
Statistics
The statistical method used to analyze grayscale values from the inner (I), middle (M) and
outer (O) dentin regions was a repeated measures one-way analysis of variance. This method
assumed independence of observations at the 3 locations in dentin and used an aggregate
grayscale value from 10 sections of each tooth (5 probed with α-MMP-2, 5 control). The
working correlation between regions of dentin was assumed to be minimal (0.1). Pilot studies
of 3 teeth indicated that a sample size of 15 teeth would have a 90% power at the level of
statistical significance of 0.05 to detect an effect size of 0.2963.
RESULTS
Antibody Specificity and MMP-2 Activity
The presence of MMP-2 in human coronal dentin and antibody specificity for MMP-2 were
verified by Western blotting and gelatin zymography.(Figure 3 A and B) Western blot analysis
of the human coronal dentin extract with α-MMP-2 revealed immunoreactivity at
approximately ~72 and ~68 kDa (proform and active form respectively). Gelatin zymography
revealed gelatinolytic activity at ~68 kDa in the extract of human coronal dentin. Western blot
analysis of the positive control rhMMP-2 with α-MMP-2 revealed the proform (~70 kDa) and
active form (~61 KDa). (Figure 3 A) The positive control rhMMP-2 also revealed gelatinolytic
activity at a slightly lower molecular weight. The slight difference in molecular weight between
the dentin MMP-2 and rhMMP-2 is likely due to the difference in post translational
modifications inherent to recombinant systems. (Figure 3 B)
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MMP-2 immunoreactivity was readily identified in the pulp, predentin and dentin.(Figure 4)
In the pulp MMP-2 was associated with the odontoblasts and the extracellular matrix. MMP-2
in association with the odontoblastic processes was clearly seen in the predentin (10–20 µm
in width) as well as in association with the newly formed, non-mineralized predentin matrix.
(Figure 5) Immunoreactive areas in the mineralized dentin included the odontoblastic processes
in the dentinal tubules as well as intertubular dentin. Greater immunoreactivity was identified
in the 100–200µm zone immediately adjacent to the predentin, as compared with middle dentin,
and was associated with the odontoblastic processes.(Figure 5) Immunoreactivity in middle
dentin was associated with the dentin matrix but not the dentinal tubule lumens. (Figure 6) A
9–10µm zone immediately adjacent to the DEJ demonstrated greater immunoreactivity than
middle or inner dentin and was associated with the dentin matrix.(Figure 7) Such intense
immunoreactivity for MMP-2 was not identified with dentin immediately adjacent to the
cementodentin junction (CDJ).(Figure 8) Analyses of 15 teeth revealed a range of levels of
staining, but the immunostaining pattern was consistent among all the samples examined.
(Table 2)
The levels of MMP-2 immunoreactivity (measured as levels of gray scale intensity) were
utilized to develop an analysis plot for each tooth section.(Figure 9) Analysis of variance
showed the mean maximum level of MMP-2 immunoreactivity of inner, middle and outer
regions of dentin were significantly different (p<0.001). Rejection of the null hypothesis, that
there was no difference in the mean maximum levels of MMP-2 immunoreactivity among the
three regions, was indicated. Pairwise contrasts indicated that all three possible section pairs
of MMP-2 immunoreactivity were significantly different in maximum mean grayscale values:
outer vs inner, mean difference = 11.1 ; p=0.0011; inner vs middle, mean difference = 16.3, p
<0.0001; outer vs middle, mean difference =27.4, p<0.0001.
Comparison of the level of immunoreactivity with subject age, subject race, subject gender,
tooth section orientation, tooth origin (maxilla or mandible), and tooth eruption status, revealed
no detectable correlation. (data not shown)
DISCUSSION
The findings of this study are consistent with other studies reporting that MMP-2 is present in
dentin.2,3,5,7,8,11,12 IHC indicates that MMP-2 is concentrated in the predentin and the inner
dentin area adjacent to the predentin, which is consistent with the hypothesis that MMP-2 is
actively involved in the organization of pre-mineralized matrix formation as well as its
subsequent mineralization.3,5,13 The increased level of inner dentin MMP-2
immunoreactivity observed by light microscopy is primarily due to the presence of MMP-2 in
association with the odontoblastic processes. As a result, ongoing odontoblastic MMP-2
expression could result in MMP-2 diffusion and sequestration thoughout the dentinal tubule
network of the intact tooth.7 The level of immunoreactivity of MMP-2 in the middle dentin
region, based on IHC, is significantly lower than the inner dentin (adjacent to the predentin)
but is consistently present. Thus, demineralized dentin matrix may represent a source of
MMP-2.7,8,12 Concentration at the DEJ suggests that MMP-2 may be involved in
establishment of the DEJ and initiation of dentin formation as other studies have suggested.
3,5,13 As dental caries progresses through the enamel and into dentin there is an initial spread
at the DEJ. The high concentration of MMP-2 at the DEJ could be in part responsible for this
clinical phenomenon.5
The notable lack of intense MMP-2 immunoreactivity in cementum and at the cementodentin
junction, to the best of our knowledge, has not been reported. Both dentin and cementum
contain fibrillar collagen, a primary substrate of MMP-2, as well as noncollagenous proteins.
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Studies in the rat reveal that there are subtle compositional and organizational differences of
matrix proteins in these two anatomically and functionally different regions.14 The difference
in MMP-2 immunoreactivity distribution may also reflect such compositional variation.
Further research identifying the relative distribution of non-collagenous proteins in human
coronal and radicular mantle dentin is warranted.
The IHC detection of MMP-2 does not mean it is active. Some studies indicate that the ability
to detect activity of MMP-2 extracted from the dentin matrix of human teeth decreases with
time, however, it is unclear whether the intact MMP-2 was missing (subject to autolysis over
time) or present but inactive.7 The inclusion criteria of this study were designed so as to not
be negatively impacted by the potential reduction in MMP-2 associated with the demineralized
matrix. Within the limits of this study, there was no correlation between the level of IHC
immunoreactivity and the age of the subjects (age range 12–30 years). Furthermore, subject
race, subject gender, tooth section orientation, tooth origin (maxilla or mandible), and tooth
eruption status did not correlate with the level of IHC immunoreactivity. Variation in staining
of sections from individual teeth and the resulting large standard deviations from the mean
(Table 2) may represent the technique sensitivity of the specimen preparation process, or
possibly different levels of MMP-2 expression from subject to subject. Previously reported
reduction in the presence of MMP-2 in older subjects7 may actually be secondary to sample
size and the pooling of teeth from individuals with very low levels of MMP-2. This notion is
consistent with recent studies that identify the potential for a range of MMP-2 expression levels
resulting from individual MMP-2 gene polymorphisms.17,18 The pooling of teeth from
multiple subjects may mask this variation in the population. Variation in MMP-2 levels among
subjects also suggests a potential relationship between the level of MMP-2 present in dentin
and individual dental caries susceptibility. Further research is indicated to help clarify these
issues.
CONCLUSIONS
MMP-2 is present throughout human coronal dentin with concentrated areas adjacent to the
predentin and DEJ. Apparent concentration adjacent to the predentin is due to MMP-2 in
association with odontoblastic processes in addition to the collagen matrix. Concentration of
MMP-2 at the DEJ is associated with the dentin matrix. Future studies are warranted to identify
if MMP-2 isolated from human dentin is able to digest collagen isolated from the same dentin
and what mechanisms are required for its activation. Also, additional studies must evaluate the
potential relationship between dentin MMP-2 concentration and caries rates.
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Sectioning technique for obtaining a 1.5 mm mesio-distal (M,D) or bucco-lingual (B,L)section
of coronal tooth structure. Parallel lines indicate approximate area of section. Arrows indicate
flow of sectioning procedures.
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Example of RGB to grayscale image processing. The yellow line represents a one pixel wide
region from pulp (P) to beyond the dentinoenamel junction (DEJ). The grayscale level at every
pixel along this line was measured to develop an analysis plot of MMP-2 immunoreactivity.
Sections were probed with α-MMP-2 (A) or Control (B) No counterstain was used.
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A) Western blot analysis with α-MMP-2, Lane 1 = 80 µg Guanidine HCl/EDTA extract of
human coronal dentin, Lane 2 = 0.1µg rhMMP-2 positive control. B) Gelatin Zymogram, Lane
1 = 160 µg Guanidine HCl/EDTA extract of human coronal dentin, Lane 2 = 0.5ng rhMMP-2
positive control. MW = molecular weight standards.
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Section of demineralized dentin probed with α-MMP-2 (A) demonstrating areas of greater
immunoreactivity adjacent to the predentin (Pr) and dentinoenamel junction (DEJ) and minimal
immunoreactivity at the cementodentin junction (CDJ). MMP-2 is visualized as a brown stain.
B is negative control.
Boushell et al. Page 11














A: Section of human coronal tooth structure demonstrating transition of intense MMP-2
immunoreactivity in inner dentin to area of less MMP-2 immunoreactivity. MMP-2 associated
with the odontoblastic processes appears to be the primary cause of intense MMP-2
immunoreactivity in inner dentin. B: Higher magnification of MMP-2 immunoreactivity in the
area of the pre-dentin. P = Pulp. Pr = Predentin. Counterstain is hematoxylin.
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A: Area typical of MMP-2 immunoreactivity in middle dentin. MMP-2 is localized primarily
with the dentin matrix and not the tubule lumens. B: Higher Magnification of MMP-2
immunoreactivity in middle dentin. Counterstain is hematoxylin.
Boushell et al. Page 13














Sections of human coronal tooth structure including a represenstive area typical of middle
dentin and the DEJ region, probed with α-MMP-2 (A) and negative control (B). Intense MMP-2
immunoreactivity adjacent to the DEJ appears to be associated with the dentin matrix.
Counterstain is hematoxylin.
Boushell et al. Page 14














Section of dentin probed with α-MMP-2 demonstrating areas of greater immunoreactivity
adjacent dentinoenamel junction (DEJ) and the disappearance of intense immunoreactivity at
the cementodentin junction (CDJ). MMP-2 is visualized as a brown stain.
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Analysis plot of MMP-2 immunoreactivity, measured on a grayscale (0–255), of the predentin
(Pr), inner (I), middle (M),and dentinoenamel junction (DEJ) regions of coronal tooth structure.
An image of coronal dentin section probed with α-MMP-2 is included for reference. The yellow
line indicates region of analysis.
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Table 1
Immunohistochemical analysis subject demographics (n = 15 teeth)
Age Gender Race Tooth Type Eruption Status
12–30 years F(9) Indian(1) Premolar(3) Unerupted(9)
 M(6) African American(5) Max Molar(8) Erupted(6)
  White(9) Mand Molar(4)  
Max = Maxillary, Mand = Mandibular
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Table 2
The difference between mean maximum grayscale values of sections probed with α-MMP-2 and control sections
in inner, middle and outer regions of human coronal dentin.
Tooth ID N = 15 Inner Dentin (SD) N = 5
measures/tooth
Middle Dentin (SD) N = 5
measures/tooth
Outer Dentin (SD) N = 5
measures/tooth
13 53.1 (30.2) 34.3 (19.6) 59.8 (31.7)
27 34.2 (5.7) 7.9 (5.5) 22.1 (6.7)
31 37.9 (10.2) 8.6 (1.3) 48.8 (10.9)
38 9.5 (3.1) 2.8 (0.9) 23.3 (4.0)
39 13.8 (5.5) 5.9 (2.8) 17.2 (4.0)
42 11.5 (1.7) 4.9 (2.6) 55.1 (23)
46 4.8 (2.5) 1.8 (1.3) 15.5 (9.4)
49 17.4 (4.6) 6.4 (6.4) 32.1 (7.2)
57 17.2 (4.2) 9.9 (4.7) 19.5 (9.4)
60 57.2 (7.1) 37.9 (7.4) 60.3 (6.6)
64 35.8 (3.4) 29.0 (2.4) 54.3 (6.9)
69 31.3 (6.6) 14.1 (3.3) 50.4 (18.8)
77 31.4 (18.3) 12.1 (11.3) 45 (17.8)
80 44.7 (11.0) 7.0 (1.9) 46.3 (14.6)
81 35.7 (13.5) 7.2 (1.9) 51.6 (13.6)
Least Squares Means 29.0 12.7 40.1
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